Global RNAi for Therapeutic Market Growth (Status and Outlook) 2025-2031

January 2025 | 115 pages | ID: GBB592E8288EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global RNAi for Therapeutic market size is predicted to grow from US$ 351 million in 2025 to US$ 3221 million in 2031; it is expected to grow at a CAGR of 44.7% from 2025 to 2031.

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

Global RNAi for Therapeutic key players include Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, etc. Global top five manufacturers hold a share over 85%.

US is the largest market, with a share over 75%, followed by EU, which has a share about 3%.

In terms of product, siRNA is the largest segment, with a share over 55%. And in terms of application, the largest application is Cancer, followed by HBV, Cardiovascular, etc.

LPI (LP Information)' newest research report, the “RNAi for Therapeutic Industry Forecast” looks at past sales and reviews total world RNAi for Therapeutic sales in 2024, providing a comprehensive analysis by region and market sector of projected RNAi for Therapeutic sales for 2025 through 2031. With RNAi for Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNAi for Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global RNAi for Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNAi for Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNAi for Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNAi for Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNAi for Therapeutic.

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi for Therapeutic market by product type, application, key players and key regions and countries.

Segmentation by Type:

• siRNA
• miRNA
• shRNA

Segmentation by Application:

• Cancer
• Cardiovascular
• HBV
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alnylam Pharmaceuticals
• Arbutus Biopharma (Tekmira)
• Arrowhead
• Dicerna Pharmaceuticals
• Mirna Therapeutics
• Quark Pharmaceuticals
• RXi Pharmaceuticals
• Silence Therapeutics
• Benitec Biopharma
• miRagen Therapeutics
• Sylentis
• Gradalis
• Sirnaomics
• Silenseed

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNAi for Therapeutic Market Size (2020-2031)
  2.1.2 RNAi for Therapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for RNAi for Therapeutic by Country/Region (2020, 2024 & 2031)
2.2 RNAi for Therapeutic Segment by Type
  2.2.1 siRNA
  2.2.2 miRNA
  2.2.3 shRNA
2.3 RNAi for Therapeutic Market Size by Type
  2.3.1 RNAi for Therapeutic Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global RNAi for Therapeutic Market Size Market Share by Type (2020-2025)
2.4 RNAi for Therapeutic Segment by Application
  2.4.1 Cancer
  2.4.2 Cardiovascular
  2.4.3 HBV
  2.4.4 Others
2.5 RNAi for Therapeutic Market Size by Application
  2.5.1 RNAi for Therapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global RNAi for Therapeutic Market Size Market Share by Application (2020-2025)

3 RNAI FOR THERAPEUTIC MARKET SIZE BY PLAYER

3.1 RNAi for Therapeutic Market Size Market Share by Player
  3.1.1 Global RNAi for Therapeutic Revenue by Player (2020-2025)
  3.1.2 Global RNAi for Therapeutic Revenue Market Share by Player (2020-2025)
3.2 Global RNAi for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAI FOR THERAPEUTIC BY REGION

4.1 RNAi for Therapeutic Market Size by Region (2020-2025)
4.2 Global RNAi for Therapeutic Annual Revenue by Country/Region (2020-2025)
4.3 Americas RNAi for Therapeutic Market Size Growth (2020-2025)
4.4 APAC RNAi for Therapeutic Market Size Growth (2020-2025)
4.5 Europe RNAi for Therapeutic Market Size Growth (2020-2025)
4.6 Middle East & Africa RNAi for Therapeutic Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas RNAi for Therapeutic Market Size by Country (2020-2025)
5.2 Americas RNAi for Therapeutic Market Size by Type (2020-2025)
5.3 Americas RNAi for Therapeutic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNAi for Therapeutic Market Size by Region (2020-2025)
6.2 APAC RNAi for Therapeutic Market Size by Type (2020-2025)
6.3 APAC RNAi for Therapeutic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNAi for Therapeutic Market Size by Country (2020-2025)
7.2 Europe RNAi for Therapeutic Market Size by Type (2020-2025)
7.3 Europe RNAi for Therapeutic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNAi for Therapeutic by Region (2020-2025)
8.2 Middle East & Africa RNAi for Therapeutic Market Size by Type (2020-2025)
8.3 Middle East & Africa RNAi for Therapeutic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNAI FOR THERAPEUTIC MARKET FORECAST

10.1 Global RNAi for Therapeutic Forecast by Region (2026-2031)
  10.1.1 Global RNAi for Therapeutic Forecast by Region (2026-2031)
  10.1.2 Americas RNAi for Therapeutic Forecast
  10.1.3 APAC RNAi for Therapeutic Forecast
  10.1.4 Europe RNAi for Therapeutic Forecast
  10.1.5 Middle East & Africa RNAi for Therapeutic Forecast
10.2 Americas RNAi for Therapeutic Forecast by Country (2026-2031)
  10.2.1 United States Market RNAi for Therapeutic Forecast
  10.2.2 Canada Market RNAi for Therapeutic Forecast
  10.2.3 Mexico Market RNAi for Therapeutic Forecast
  10.2.4 Brazil Market RNAi for Therapeutic Forecast
10.3 APAC RNAi for Therapeutic Forecast by Region (2026-2031)
  10.3.1 China RNAi for Therapeutic Market Forecast
  10.3.2 Japan Market RNAi for Therapeutic Forecast
  10.3.3 Korea Market RNAi for Therapeutic Forecast
  10.3.4 Southeast Asia Market RNAi for Therapeutic Forecast
  10.3.5 India Market RNAi for Therapeutic Forecast
  10.3.6 Australia Market RNAi for Therapeutic Forecast
10.4 Europe RNAi for Therapeutic Forecast by Country (2026-2031)
  10.4.1 Germany Market RNAi for Therapeutic Forecast
  10.4.2 France Market RNAi for Therapeutic Forecast
  10.4.3 UK Market RNAi for Therapeutic Forecast
  10.4.4 Italy Market RNAi for Therapeutic Forecast
  10.4.5 Russia Market RNAi for Therapeutic Forecast
10.5 Middle East & Africa RNAi for Therapeutic Forecast by Region (2026-2031)
  10.5.1 Egypt Market RNAi for Therapeutic Forecast
  10.5.2 South Africa Market RNAi for Therapeutic Forecast
  10.5.3 Israel Market RNAi for Therapeutic Forecast
  10.5.4 Turkey Market RNAi for Therapeutic Forecast
10.6 Global RNAi for Therapeutic Forecast by Type (2026-2031)
10.7 Global RNAi for Therapeutic Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market RNAi for Therapeutic Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alnylam Pharmaceuticals
  11.1.1 Alnylam Pharmaceuticals Company Information
  11.1.2 Alnylam Pharmaceuticals RNAi for Therapeutic Product Offered
  11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Alnylam Pharmaceuticals Main Business Overview
  11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Arbutus Biopharma (Tekmira)
  11.2.1 Arbutus Biopharma (Tekmira) Company Information
  11.2.2 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Offered
  11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Arbutus Biopharma (Tekmira) Main Business Overview
  11.2.5 Arbutus Biopharma (Tekmira) Latest Developments
11.3 Arrowhead
  11.3.1 Arrowhead Company Information
  11.3.2 Arrowhead RNAi for Therapeutic Product Offered
  11.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Arrowhead Main Business Overview
  11.3.5 Arrowhead Latest Developments
11.4 Dicerna Pharmaceuticals
  11.4.1 Dicerna Pharmaceuticals Company Information
  11.4.2 Dicerna Pharmaceuticals RNAi for Therapeutic Product Offered
  11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Dicerna Pharmaceuticals Main Business Overview
  11.4.5 Dicerna Pharmaceuticals Latest Developments
11.5 Mirna Therapeutics
  11.5.1 Mirna Therapeutics Company Information
  11.5.2 Mirna Therapeutics RNAi for Therapeutic Product Offered
  11.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mirna Therapeutics Main Business Overview
  11.5.5 Mirna Therapeutics Latest Developments
11.6 Quark Pharmaceuticals
  11.6.1 Quark Pharmaceuticals Company Information
  11.6.2 Quark Pharmaceuticals RNAi for Therapeutic Product Offered
  11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Quark Pharmaceuticals Main Business Overview
  11.6.5 Quark Pharmaceuticals Latest Developments
11.7 RXi Pharmaceuticals
  11.7.1 RXi Pharmaceuticals Company Information
  11.7.2 RXi Pharmaceuticals RNAi for Therapeutic Product Offered
  11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 RXi Pharmaceuticals Main Business Overview
  11.7.5 RXi Pharmaceuticals Latest Developments
11.8 Silence Therapeutics
  11.8.1 Silence Therapeutics Company Information
  11.8.2 Silence Therapeutics RNAi for Therapeutic Product Offered
  11.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Silence Therapeutics Main Business Overview
  11.8.5 Silence Therapeutics Latest Developments
11.9 Benitec Biopharma
  11.9.1 Benitec Biopharma Company Information
  11.9.2 Benitec Biopharma RNAi for Therapeutic Product Offered
  11.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Benitec Biopharma Main Business Overview
  11.9.5 Benitec Biopharma Latest Developments
11.10 miRagen Therapeutics
  11.10.1 miRagen Therapeutics Company Information
  11.10.2 miRagen Therapeutics RNAi for Therapeutic Product Offered
  11.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 miRagen Therapeutics Main Business Overview
  11.10.5 miRagen Therapeutics Latest Developments
11.11 Sylentis
  11.11.1 Sylentis Company Information
  11.11.2 Sylentis RNAi for Therapeutic Product Offered
  11.11.3 Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Sylentis Main Business Overview
  11.11.5 Sylentis Latest Developments
11.12 Gradalis
  11.12.1 Gradalis Company Information
  11.12.2 Gradalis RNAi for Therapeutic Product Offered
  11.12.3 Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Gradalis Main Business Overview
  11.12.5 Gradalis Latest Developments
11.13 Sirnaomics
  11.13.1 Sirnaomics Company Information
  11.13.2 Sirnaomics RNAi for Therapeutic Product Offered
  11.13.3 Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Sirnaomics Main Business Overview
  11.13.5 Sirnaomics Latest Developments
11.14 Silenseed
  11.14.1 Silenseed Company Information
  11.14.2 Silenseed RNAi for Therapeutic Product Offered
  11.14.3 Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Silenseed Main Business Overview
  11.14.5 Silenseed Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. RNAi forTherapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. RNAi forTherapeutic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of siRNA
Table 4. Major Players of miRNA
Table 5. Major Players of shRNA
Table 6. RNAi forTherapeutic Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global RNAi forTherapeutic Market Size byType (2020-2025) & ($ millions)
Table 8. Global RNAi forTherapeutic Market Size Market Share byType (2020-2025)
Table 9. RNAi forTherapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global RNAi forTherapeutic Market Size by Application (2020-2025) & ($ millions)
Table 11. Global RNAi forTherapeutic Market Size Market Share by Application (2020-2025)
Table 12. Global RNAi forTherapeutic Revenue by Player (2020-2025) & ($ millions)
Table 13. Global RNAi forTherapeutic Revenue Market Share by Player (2020-2025)
Table 14. RNAi forTherapeutic Key Players Head office and Products Offered
Table 15. RNAi forTherapeutic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global RNAi forTherapeutic Market Size by Region (2020-2025) & ($ millions)
Table 19. Global RNAi forTherapeutic Market Size Market Share by Region (2020-2025)
Table 20. Global RNAi forTherapeutic Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global RNAi forTherapeutic Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas RNAi forTherapeutic Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas RNAi forTherapeutic Market Size Market Share by Country (2020-2025)
Table 24. Americas RNAi forTherapeutic Market Size byType (2020-2025) & ($ millions)
Table 25. Americas RNAi forTherapeutic Market Size Market Share byType (2020-2025)
Table 26. Americas RNAi forTherapeutic Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas RNAi forTherapeutic Market Size Market Share by Application (2020-2025)
Table 28. APAC RNAi forTherapeutic Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC RNAi forTherapeutic Market Size Market Share by Region (2020-2025)
Table 30. APAC RNAi forTherapeutic Market Size byType (2020-2025) & ($ millions)
Table 31. APAC RNAi forTherapeutic Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe RNAi forTherapeutic Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe RNAi forTherapeutic Market Size Market Share by Country (2020-2025)
Table 34. Europe RNAi forTherapeutic Market Size byType (2020-2025) & ($ millions)
Table 35. Europe RNAi forTherapeutic Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa RNAi forTherapeutic Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa RNAi forTherapeutic Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa RNAi forTherapeutic Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of RNAi forTherapeutic
Table 40. Key Market Challenges & Risks of RNAi forTherapeutic
Table 41. Key IndustryTrends of RNAi forTherapeutic
Table 42. Global RNAi forTherapeutic Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global RNAi forTherapeutic Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global RNAi forTherapeutic Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global RNAi forTherapeutic Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Alnylam Pharmaceuticals Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 47. Alnylam Pharmaceuticals RNAi forTherapeutic Product Offered
Table 48. Alnylam Pharmaceuticals RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Alnylam Pharmaceuticals Main Business
Table 50. Alnylam Pharmaceuticals Latest Developments
Table 51. Arbutus Biopharma (Tekmira) Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 52. Arbutus Biopharma (Tekmira) RNAi forTherapeutic Product Offered
Table 53. Arbutus Biopharma (Tekmira) RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Arbutus Biopharma (Tekmira) Main Business
Table 55. Arbutus Biopharma (Tekmira) Latest Developments
Table 56. Arrowhead Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 57. Arrowhead RNAi forTherapeutic Product Offered
Table 58. Arrowhead RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Arrowhead Main Business
Table 60. Arrowhead Latest Developments
Table 61. Dicerna Pharmaceuticals Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 62. Dicerna Pharmaceuticals RNAi forTherapeutic Product Offered
Table 63. Dicerna Pharmaceuticals RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Dicerna Pharmaceuticals Main Business
Table 65. Dicerna Pharmaceuticals Latest Developments
Table 66. MirnaTherapeutics Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 67. MirnaTherapeutics RNAi forTherapeutic Product Offered
Table 68. MirnaTherapeutics RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. MirnaTherapeutics Main Business
Table 70. MirnaTherapeutics Latest Developments
Table 71. Quark Pharmaceuticals Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 72. Quark Pharmaceuticals RNAi forTherapeutic Product Offered
Table 73. Quark Pharmaceuticals RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Quark Pharmaceuticals Main Business
Table 75. Quark Pharmaceuticals Latest Developments
Table 76. RXi Pharmaceuticals Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 77. RXi Pharmaceuticals RNAi forTherapeutic Product Offered
Table 78. RXi Pharmaceuticals RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. RXi Pharmaceuticals Main Business
Table 80. RXi Pharmaceuticals Latest Developments
Table 81. SilenceTherapeutics Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 82. SilenceTherapeutics RNAi forTherapeutic Product Offered
Table 83. SilenceTherapeutics RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. SilenceTherapeutics Main Business
Table 85. SilenceTherapeutics Latest Developments
Table 86. Benitec Biopharma Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 87. Benitec Biopharma RNAi forTherapeutic Product Offered
Table 88. Benitec Biopharma RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Benitec Biopharma Main Business
Table 90. Benitec Biopharma Latest Developments
Table 91. miRagenTherapeutics Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 92. miRagenTherapeutics RNAi forTherapeutic Product Offered
Table 93. miRagenTherapeutics RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. miRagenTherapeutics Main Business
Table 95. miRagenTherapeutics Latest Developments
Table 96. Sylentis Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 97. Sylentis RNAi forTherapeutic Product Offered
Table 98. Sylentis RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Sylentis Main Business
Table 100. Sylentis Latest Developments
Table 101. Gradalis Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 102. Gradalis RNAi forTherapeutic Product Offered
Table 103. Gradalis RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Gradalis Main Business
Table 105. Gradalis Latest Developments
Table 106. Sirnaomics Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 107. Sirnaomics RNAi forTherapeutic Product Offered
Table 108. Sirnaomics RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Sirnaomics Main Business
Table 110. Sirnaomics Latest Developments
Table 111. Silenseed Details, CompanyType, RNAi forTherapeutic Area Served and Its Competitors
Table 112. Silenseed RNAi forTherapeutic Product Offered
Table 113. Silenseed RNAi forTherapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Silenseed Main Business
Table 115. Silenseed Latest Developments



LIST OFFIGURES

Figure 1. RNAi forTherapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNAi forTherapeutic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. RNAi forTherapeutic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. RNAi forTherapeutic Sales Market Share by Country/Region (2024)
Figure 8. RNAi forTherapeutic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global RNAi forTherapeutic Market Size Market Share byType in 2024
Figure 10. RNAi forTherapeutic in Cancer
Figure 11. Global RNAi forTherapeutic Market: Cancer (2020-2025) & ($ millions)
Figure 12. RNAi forTherapeutic in Cardiovascular
Figure 13. Global RNAi forTherapeutic Market: Cardiovascular (2020-2025) & ($ millions)
Figure 14. RNAi forTherapeutic in HBV
Figure 15. Global RNAi forTherapeutic Market: HBV (2020-2025) & ($ millions)
Figure 16. RNAi forTherapeutic in Others
Figure 17. Global RNAi forTherapeutic Market: Others (2020-2025) & ($ millions)
Figure 18. Global RNAi forTherapeutic Market Size Market Share by Application in 2024
Figure 19. Global RNAi forTherapeutic Revenue Market Share by Player in 2024
Figure 20. Global RNAi forTherapeutic Market Size Market Share by Region (2020-2025)
Figure 21. Americas RNAi forTherapeutic Market Size 2020-2025 ($ millions)
Figure 22. APAC RNAi forTherapeutic Market Size 2020-2025 ($ millions)
Figure 23. Europe RNAi forTherapeutic Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa RNAi forTherapeutic Market Size 2020-2025 ($ millions)
Figure 25. Americas RNAi forTherapeutic Value Market Share by Country in 2024
Figure 26. United States RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC RNAi forTherapeutic Market Size Market Share by Region in 2024
Figure 31. APAC RNAi forTherapeutic Market Size Market Share byType (2020-2025)
Figure 32. APAC RNAi forTherapeutic Market Size Market Share by Application (2020-2025)
Figure 33. China RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 37. India RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe RNAi forTherapeutic Market Size Market Share by Country in 2024
Figure 40. Europe RNAi forTherapeutic Market Size Market Share byType (2020-2025)
Figure 41. Europe RNAi forTherapeutic Market Size Market Share by Application (2020-2025)
Figure 42. Germany RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 43.France RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 44. UK RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa RNAi forTherapeutic Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa RNAi forTherapeutic Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa RNAi forTherapeutic Market Size Market Share by Application (2020-2025)
Figure 50. Egypt RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries RNAi forTherapeutic Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 56. APAC RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 57. Europe RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 59. United States RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 60. Canada RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 61. Mexico RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 62. Brazil RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 63. China RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 64. Japan RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 65. Korea RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 67. India RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 68. Australia RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 69. Germany RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 70.France RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 71. UK RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 72. Italy RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 73. Russia RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 74. Egypt RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 75. South Africa RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 76. Israel RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 77.Turkey RNAi forTherapeutic Market Size 2026-2031 ($ millions)
Figure 78. Global RNAi forTherapeutic Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global RNAi forTherapeutic Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries RNAi forTherapeutic Market Size 2026-2031 ($ millions)